EcoR1 Capital’s Oric Pharmaceuticals ORIC Stock Holding History

EcoR1 Capital’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$85.2M	Hold	6,728,116	–	–	3.62%	7
2025 Q4	$55M	Hold	6,728,116	–	–	2.5%	9
2025 Q3	$80.7M	Buy	6,728,116 +5,110,048	+316%	+$53.8M	3.87%	8
2025 Q2	$16.4M	Sell	1,618,068 -1,800,000	-53%	-$12.1M	0.97%	21
2025 Q1	$19.1M	Hold	3,418,068	–	–	1.13%	15
2024 Q4	$27.6M	Hold	3,418,068	–	–	1.04%	21
2024 Q3	$35M	Hold	3,418,068	–	–	1.2%	21
2024 Q2	$24.2M	Hold	3,418,068	–	–	0.74%	27
2024 Q1	$47M	Hold	3,418,068	–	–	1.19%	21
2023 Q4	$31.4M	Hold	3,418,068	–	–	0.82%	24
2023 Q3	$20.7M	Hold	3,418,068	–	–	0.7%	28
2023 Q2	$26.5M	Hold	3,418,068	–	–	0.65%	21
2023 Q1	$19.5M	Hold	3,418,068	–	–	0.63%	29
2022 Q4	$20.1M	Hold	3,418,068	–	–	0.61%	27
2022 Q3	$10.9M	Hold	3,418,068	–	–	0.32%	37
2022 Q2	$15.3M	Hold	3,418,068	–	–	0.53%	33
2022 Q1	$18.3M	Sell	3,418,068 -50,876	-1%	-$458K	0.57%	34
2021 Q4	$51M	Hold	3,468,944	–	–	1.63%	18
2021 Q3	$72.5M	Buy	3,468,944 +376,726	+12%	+$7.64M	2.52%	11
2021 Q2	$54.7M	Hold	3,092,218	–	–	2.04%	13
2021 Q1	$75.8M	Hold	3,092,218	–	–	3.36%	10
2020 Q4	$105M	Buy	3,092,218 +450,000	+17%	+$12.9M	5.63%	6
2020 Q3	$66.1M	Hold	2,642,218	–	–	4.71%	7
2020 Q2	$89.1M	Buy	+2,642,218	New	+$84.3M	6.58%	3

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital's ORIC Position: Q1 2026 in Review

EcoR1 Capital held its Oric Pharmaceuticals (ORIC) position steady in Q1 2026 at 6,728,116 shares worth $85.2M. The position accounts for 3.62% of the portfolio, ranked #7.

EcoR1 Capital first reported a position in ORIC in Q2 2020 and has held it in 24 quarters since. The position peaked at $105M in Q4 2020. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

EcoR1 Capital held 6,728,116 shares of Oric Pharmaceuticals worth $85.2M as of Q1 2026.
EcoR1 Capital left its Oric Pharmaceuticals share count unchanged in Q1 2026.
Oric Pharmaceuticals made up 3.62% of EcoR1 Capital's portfolio in Q1 2026, its #7 holding.
EcoR1 Capital first reported a position in Oric Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
EcoR1 Capital's Oric Pharmaceuticals position peaked at $105M in Q4 2020.
182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on EcoR1 Capital's 13F filing for Q1 2026, filed 15 May 2026.